
						
							
						
						
							<!--
							google_ad_client = "pub-5806585833518451";
							/* 300x250, created 6/2/09 - iposol_ipo_detail_top */
							google_ad_slot = "4379562531";
							google_ad_width = 300;
							google_ad_height = 250;
									-->
							
							
							
						

						Incorporate in 1997, Celestial Labs Limited is in the business of research, development and manufacturing of biotechnology products. Celestial provides customized enterprise solutions, bio-informatics services and is also involved in development of biopharmaceuticals and industrial enzymes.Celestial offers Industrial Biotechnology Products (Industrial Enzymes), Drug Molecule Development & Licensing, Clinical Data Management, Clinical Research Trials and Bioinformatics Services (Molecular Modeling).Celestial Labs Limited is located at Banjara Hills, Hyderabad, India and is an ISO 9001-2000 certified company.

						
						
							
						
						

						

						

						
							<!--
								google_ad_client = "pub-5806585833518451";
								/* 300x250, created 9/3/09 - IPO Detail Center */
								google_ad_slot = "7910498455";
								google_ad_width = 300;
								google_ad_height = 250;
								-->
							
							
							
						

						Objects of the Issue:The objects of the Issue are to achieve the benefits of listing on the Stock Exchanges & to raise capital for the 1. Expansion of Manufacturing & R&D Facilities;2. Setting-up of overseas Offices;3. Providing additional Working Capital.

						Issue Detail:
						  »»  Issue Open: Jun 18, 2007 - Jun 22, 2007
							  »»  Issue Type: Fixed Price Issue IPO
							  »»  Issue Size: 5,000,000 Equity Shares of Rs 10 aggregating up to Rs 30.00 Cr
							
							
							  »»  Face Value: Rs 10 Per Equity Share
							  »»  Issue Price: Rs. 60 Per Equity Share
							  »»  Market Lot: 90 Shares
							  »»  Minimum Order Quantity: 90 Shares
							  »»  Listing At: BSE, NSE
						

						


						


						
							
						

						
							
						
					
